S-BIOTEK AF 15. MARTS 2006 2 ApS: Financial statements 2017
CVR: 29422362
Source: annual report 2017, Danish Business Authority
01/07/2016 – 30/06/2017
S-BIOTEK AF 15. MARTS 2006 2 ApS (CVR 29422362) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -8,000 and a net result of DKK -3,582 compared with DKK -3,277 the year before. Equity in the 2017 report amounted to DKK 104,847. The solvency ratio was 62%.
- Gross Profit
- DKK -8,000
- Profit/Loss
- DKK -3,582
- Equity
- DKK 104,847
- Total Assets
- DKK 169,237
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -8K | -4K | 105K | - |
| 2016 | - | -8K | -3K | 108K | - |
| 2015 | - | -5K | -482 | 112K | - |
| 2014 | - | -5K | -540 | 112K | - |
| 2013 | - | -5K | -520 | 113K | - |
Official annual report
Keep an eye on S-BIOTEK AF 15. MARTS 2006 2 ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout S-BIOTEK AF 15. MARTS 2006 2 ApS
S-BIOTEK AF 15. MARTS 2006 2 ApS was a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2006. The company has been dissolved on 16 February 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named DS 1501 ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -5,000 and a net result of DKK -8,014 compared with DKK -5,841 the year before. Equity in the 2025 report amounted to DKK -33,261.
